ClinicalTrialsFinder

MET Alteration Clinical Trials in Washington D.C., District of Columbia

1 recruitingWashington D.C., District of Columbia

Showing 1–1 of 1 trials

Recruiting
Phase 1Phase 2

FIH Trial of VERT-002 in Patients With Locally Advanced or Metastatic Solid Tumors With MET Alterations

Solid TumorMET Alteration
Pierre Fabre Medicament140 enrolled19 locationsNCT06669117